website

Canwell Medical Participates in IFOSMA 2022 Grand Meeting

Navigation

  1. Introduction to IFOSMA 2022
  2. Canwell Medical’s Diversified Combination and Innovative Solutions in Sports Medicine
  3. Canwell Medical’s Diversified Combination and Innovative Solutions in Sports Medicine

Introduction to IFOSMA 2022

From October 28th to 30th, 2022, the 18th International Forum on Orthopedic Sports Medicine and Arthroscopic Surgery (IFOSMA), was successfully held in Xiamen. The conference, which is the most influential brand international academic conference in China’s sports medicine field, had the theme of “Function First, Early Rehabilitation, and Return to Sports”. It successfully completed various agendas through a combination of online and offline methods. Professor Chen Shiyi, Director of the Institute of Sports Medicine, Fudan University, chaired the meeting, and Professor Zhang Yingze, Academician of the Chinese Academy of Engineering, Professor Cheng Weiming, Counselor of the Shanghai, and Liu Bin, Director of the Greater Bay Branch Center for Medical Device Technology Evaluation and Inspection of the State Food and Drug Administration, Hao Deming, Executive Vice President and Secretary-General of the Association of Non-public Medical Institutions, were among the invited guests. Fang Ming, chairman of Canwell Medical, participated in this event with a full range of sports medicine products.

Professor Li Guoping, Former Director of the Institute of Sports Medicine of the State Sports General Administration, Zhang Lingyi, Secretary-General of the Shanghai Medical and Health Development Foundation, Director of the Department of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, National Infectious Diseases Director Zhang Wenhong of the Medical Center, General Liu Yujie of the First Medical Center of the Chinese People’s Liberation Army General Hospital, Professor Li Jian, Director of the Sports Medicine Center of West China Hospital of Sichuan University, Jeffrey Bernstein, President of UPMC China and Vice President of UPMC International, and other relevant leaders also attended the meeting.

a doctor in canwell watching the computer
a doctor in Canwell

Canwell Medical’s Diversified Combination and Innovative Solutions in Sports Medicine

In this IFOSMA grand meeting, Canwell demonstrated the diversified combination and innovative solutions of the sports medicine product line. For example the CanFix micro-movement series for acromioclavicular joint dislocation and syndesmosis injury – endo button and other products, with the core values of professionalism, responsibility, and confidence. They kept up with the pulse of the development of the times and paid attention to the frontier of transportation medicine. Canwell is committed to building a domestic medical device brand that is “affordable for ordinary people and more suitable for Chinese people” to better serve the clinic and join hands with the clinical joint promotion of new progress in the field of sports medicine diagnosis and treatment, which has been widely recognized by experts in the field of sports medicine.

Canwell Medical’s Diversified Combination and Innovative Solutions in Sports Medicine

For a long time, Canwell has been adhering to the corporate tenet of “Science and Technology Serving Health”. And has actively participated in supporting academic exchanges and technical cooperation. Their scientific research platform focuses on the R&D, production, and sales of new biological implant materials, and is committed to promoting the localization and quality of orthopedic medical device brands. Canwell is an advocate and practitioner of industry-university-research cooperation. The transformation of scientific and technological achievements. Canwell will take this opportunity to continuously focus on the clinical pain points. The needs of sports medicine, develop innovations and meet challenges. Accelerate the deep integration of production, education, research, and medicine. To make due contributions to the localization of medical implant materials in China and the realization of import substitution.

Scroll to Top